Proteomics Market by Component (Instruments, Reagents, and Services) and Application (Drug Discovery, Disease Diagnosis, and Others): Opportunity Analysis and Industry Forecast, 2018 - 2025

 The global proteomics market was valued at $24,361million in 2017, and is expected to reach $72,444 million by 2025, growing at a CAGR of 14.5% during the forecast period. Proteomics is the study of the structure and functions of proteins. It is a complex study as compared to genomics, as genomes are constant, while proteomes differ depending on the cells and time.

The global proteomics market has witnessed significant growth over the past few years, owing to increased utility of proteomics in the diagnosis of diseases and identification of potential new drugs for the treatment of various diseases. Factors such as rise in focus of key players toward product development, surge in R&D expenditure on proteomics, increase in popularity for personalized medicines, and technological advancements in proteomics are expected to drive the market. However, stringent regulatory approvals, high cost of instruments, and dearth of qualified researchers are expected to hamper the market growth.

The global proteomics market is segmented based on component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is subsegmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry.

Likewise, the chromatography segment is subclassified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography. The applications covered in the study include drug discovery, disease diagnosis, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key companies profiled in the report include Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation. The other players included in the value chain analysis (but not included in the report) are Becton, Dickinson and Company, Caprion Biosciences, and others.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the global proteomics market along with the current trends and future estimations to elucidate the imminent investment pockets.

• The report provides a quantitative analysis for the period of 2017–2025 to enable stakeholders to capitalize on the prevailing market opportunities.

• Extensive analysis of the market by components helps to understand the various types of instruments used across geographies.

• Comprehensive analysis of all regions is provided to determine the prevailing opportunities in these regions.

• Key market players have been profiled in the report and their strategies have been analyzed thoroughly to understand the competitive outlook of the global market.

• Extensive analysis of the market is conducted by closely following key product positioning, and monitoring the top contenders within the market framework.

Key Market Segments

By Component

• Instruments

o Microarray

o Spectrometry

§ Mass Spectrometry

§ NMR Spectrometry

o X-ray Crystallography

o Chromatography

§ HPLC Systems

§ Ion Chromatography

§ Affinity Chromatography

§ Supercritical Fluid Chromatography

o Electrophoresis

o Surface Plasmon Resonance

o Protein Fractionation Reagents

• Reagents

o Microarray

o Spectroscopy

o X-ray Crystallography

o Chromatography

o Electrophoresis

o Immunoassay

o Protein Fractionation Reagents

• Services

By Application

• Drug Discovery

• Disease Diagnosis

• Others

By Region

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

• Asia-Pacific

o Japan

o China

o India

o Australia

o Rest of Asia-Pacific

 

• LAMEA

o Brazil

o Saudi Arabia

o South Africa

o Rest of LAME

Chapter: 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top winning strategies

3.2.2. Top investment pockets

3.2.3. Top player positioning

3.3. Porter’s five forces analysis

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in popularity of personalized medicines

3.4.1.2. Upsurge in R&D expenditure

3.4.1.3. Technological advancements associated with proteomics components

3.4.2. Restraints

3.4.2.1. High costs associated with proteomics components

3.4.2.2. Dearth of skilled professionals

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities associated with biomarker identification

3.4.3.2. Developments in mass spectrometry-based proteomics

Chapter: 4: PROTEOMICS MARKET, BY COMPONENT

4.1. Overview

4.1.1. Market size and forecast

4.2. Reagents

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast

4.2.3. Microarray

4.2.3.1. Market size and forecast

4.2.4. Spectrometry

4.2.4.1. Market size and forecast

4.2.5. X-ray crystallography

4.2.5.1. Market size and forecast

4.2.6. Chromatography

4.2.6.1. Market size and forecast

4.2.7. Electrophoresis

4.2.7.1. Market size and forecast

4.2.8. Immunoassay

4.2.8.1. Market size and forecast

4.2.9. Protein fractionation reagents

4.2.9.1. Market size and forecast

4.2.10. Market analysis, by country

4.3. Instruments

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast

4.3.3. Microarray

4.3.3.1. Market size and forecast

4.3.4. Spectrometry

4.3.4.1. Market size and forecast

4.3.4.1.1. Mass spectrometry

4.3.4.1.1.1. Market size and forecast

4.3.4.1.2. NMR spectrometry

4.3.4.1.2.1. Market size and forecast

4.3.5. Chromatography

4.3.5.1. Market size and forecast

4.3.5.1.1. HPLC systems

4.3.5.1.1.1. Market size and forecast

4.3.5.1.2. Ion chromatography

4.3.5.1.2.1. Market size and forecast

4.3.5.1.3. Affinity chromatography

4.3.5.1.3.1. Market size and forecast

4.3.5.1.4. Supercritical fluid chromatography

4.3.5.1.4.1. Market size and forecast

4.3.6. Electrophoresis

4.3.6.1. Market size and forecast

4.3.7. Surface plasmon resonance

4.3.7.1. Market size and forecast

4.3.8. X-ray crystallography

4.3.8.1. Market size and forecast

4.3.9. Protein fractionation systems

4.3.9.1. Market size and forecast

4.3.10. Market analysis, by country

4.4. Services

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast

4.4.3. Market analysis, by country

Chapter: 5: PROTEOMICS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Drug discovery

5.2.1. Market size and forecast

5.2.2. Market analysis, by country

5.3. Disease diagnosis

5.3.1. Market size and forecast

5.3.2. Market analysis, by country

5.4. Others

5.4.1. Market size and forecast

5.4.2. Market analysis, by country

Chapter: 6: PROTEOMICS MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities

6.2.2. Market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. proteomics market, by component

6.2.2.1.2. U.S. proteomics market, by application

6.2.2.2. Canada

6.2.2.2.1. Canada proteomics market, by component

6.2.2.2.2. Canada proteomics market, by application

6.2.2.3. Mexico

6.2.2.3.1. Mexico proteomics market, by component

6.2.2.3.2. Mexico proteomics market, by application

6.2.3. North America proteomics market, by component

6.2.4. North America proteomics market, by application

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities

6.3.2. Market size and forecast, by country

6.3.2.1. Germany

6.3.2.1.1. Germany proteomics market, by component

6.3.2.1.2. Germany proteomics market, by application

6.3.2.2. France

6.3.2.2.1. France proteomics market, by component

6.3.2.2.2. France proteomics market, by application

6.3.2.3. UK

6.3.2.3.1. UK proteomics market, by component

6.3.2.3.2. UK proteomics market, by application

6.3.2.4. Italy

6.3.2.4.1. Italy proteomics market, by component

6.3.2.4.2. ITALY proteomics market, by application

6.3.2.5. Spain

6.3.2.5.1. Spain proteomics market, by component

6.3.2.5.2. Spain proteomics market, by application

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe proteomics market, by component

6.3.2.6.2. Rest of Europe proteomics market, by application

6.3.3. Europe proteomics market, by component

6.3.4. Europe proteomics market, by application

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities

6.4.1.1. Japan

6.4.1.1.1. Japan proteomics market, by component

6.4.1.1.2. Japan proteomics market, by application

6.4.1.2. China

6.4.1.2.1. China proteomics market, by component

6.4.1.2.2. China proteomics market, by application

6.4.1.3. India

6.4.1.3.1. India proteomics market, by component

6.4.1.3.2. India proteomics market, by application

6.4.1.4. Australia

6.4.1.4.1. Australia proteomics market, by component

6.4.1.4.2. Australia proteomics market, by application

6.4.1.5. South Korea

6.4.1.5.1. South Korea proteomics market, by component

6.4.1.5.2. South Korea proteomics market, by application

6.4.1.6. Rest of Asia-Pacific

6.4.1.6.1. Rest of Asia-Pacific proteomics market, by component

6.4.1.6.2. Rest of Asia-Pacific proteomics market, by application

6.4.2. Asia-Pacific proteomics market, by component

6.4.3. Asia-Pacific proteomics market, by application

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities

6.5.2. Market size and forecast, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil proteomics market, by component

6.5.2.1.2. Brazil proteomics market, by application

6.5.2.2. Saudi Arabia

6.5.2.2.1. Saudi Arabia proteomics market, by component

6.5.2.2.2. Saudi Arabia proteomics market, by application

6.5.2.3. South Africa

6.5.2.3.1. South Africa proteomics market, by component

6.5.2.3.2. South Africa proteomics market, by application

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Rest of LAMEA proteomics market, by component

6.5.2.4.2. Rest of LAMEA proteomics market, by application

6.5.3. LAMEA proteomics market, by component

6.5.4. LAMEA proteomics market, by application

Chapter: 7: COMPANY PROFILES

7.1. AGILENT TECHNOLOGIES, INC.

7.1.1. Company overview

7.1.2. Company snapshot

7.1.3. Operating business segments

7.1.4. Product portfolio

7.1.5. Business performance

7.1.6. Key strategic moves and developments

7.2. DANAHER CORPORATION (BECKMAN COULTER, INC.)

7.2.1. Company overview

7.2.2. Company snapshot

7.2.3. Operating business segments

7.2.4. Product portfolio

7.2.5. Business performance

7.3. LI-COR, INC.

7.3.1. Company overview

7.3.2. Company snapshot

7.3.3. Operating business segments

7.3.4. Product portfolio

7.4. PERKINELMER INC.

7.4.1. Company overview

7.4.2. Company snapshot

7.4.3. Operating business segments

7.4.4. Product Portfolio

7.4.5. Business performance

7.4.6. Key strategic moves and developments

7.5. THERMO FISHER SCIENTIFIC, INC.

7.5.1. Company overview

7.5.2. Company snapshot

7.5.3. Operating business segments

7.5.4. Product portfolio

7.5.5. Business performance

7.5.6. Key strategic moves and developments

7.6. HORIBA, LTD.

7.6.1. Company overview

7.6.2. Company snapshot

7.6.3. Operating business segments

7.6.4. Product portfolio

7.6.5. Business performance

7.7. BIO-RAD LABORATORIES, INC.

7.7.1. Company overview

7.7.2. Company snapshot

7.7.3. Operating business segments

7.7.4. Product type Portfolio

7.7.5. Business performance

7.7.6. Key strategic moves and developments

7.8. BRUKER CORPORATION (BECKMAN COULTER, INC.)

7.8.1. Company overview

7.8.2. Company snapshot

7.8.3. Operating business segments

7.8.4. Product type portfolio

7.8.5. Business performance

7.8.6. Key strategic moves and developments

7.9. GE HEALTHCARE (GENERAL ELECTRIC)

7.9.1. Company overview

7.9.2. Company snapshot

7.9.3. Operating business segments

7.9.4. Product Portfolio

7.9.5. Business performance

7.10. WATERS CORPORATION (BECKMAN COULTER, INC.)

7.10.1. Company overview

7.10.2. Company snapshot

7.10.3. Operating business segments

7.10.4. Product type portfolio

7.10.5. Business performance

7.10.6. Key strategic moves and development

LIST OF TABLES

TABLE 01. GLOBAL PROTEOMICS REAGENTS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 02. PROTEOMICS REAGENTS MARKET, BY REGION, 2017–2025 ($MILLION)

TABLE 03. PROTEOMICS REAGENTS MARKET, BY COMPONENT TYPE, 2017–2025 ($MILLION)

TABLE 04. PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2017–2025 ($MILLION)

TABLE 05. PROTEOMICS INSTRUMENTS MARKET, BY COMPONENT TYPE, 2017–2025 ($MILLION)

TABLE 06. PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, BY TYPE, 2017–2025 ($MILLION)

TABLE 07. PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2017–2025 ($MILLION)

TABLE 08. PROTEOMICS SERVICES MARKET, BY REGION, 2017–2025 ($MILLION)

TABLE 09. GLOBAL PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 10. PROTEOMICS MARKET FOR DRUG DISCOVERY, BY REGION, 2017–2025 ($MILLION)

TABLE 11. PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2017–2025 ($MILLION)

TABLE 12. PROTEOMICS MARKET FOR OTHERS, BY REGION, 2017–2025 ($MILLION)

TABLE 13. PROTEOMICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 14. NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 15. U.S. PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 16. U.S. PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 17. CANADA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 18. CANADA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 19. MEXICO PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 20. MEXICO PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 21. NORTH AMERICA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 22. NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 23. EUROPE PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 24. GERMANY PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 25. GERMANY PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 26. FRANCE PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 27. FRANCE PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 28. UK PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 29. UK PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 30. ITALY PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 31. ITALY PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 32. SPAIN PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 33. SPAIN PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 34. REST OF EUROPE PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 35. REST OF EUROPE PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 36. EUROPE PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 37. EUROPE PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 38. ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 39. JAPAN PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 40. JAPAN PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 41. CHINA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 42. CHINA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 43. INDIA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 44. INDIA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 45. AUSTRALIA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 46. AUSTRALIA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 47. SOUTH KOREA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 48. SOUTH KOREA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 49. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 50. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 51. ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 52. ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 53. LAMEA PROTEOMICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 54. BRAZIL PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 55. BRAZIL PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 56. SAUDI ARABIA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 57. SAUDI ARABIA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 58. SOUTH AFRICA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 59. SOUTH AFRICA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 60. REST OF LAMEA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 61. REST OF LAMEA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 62. LAMEA PROTEOMICS MARKET, BY COMPONENT, 2017–2025 ($MILLION)

TABLE 63. LAMEA PROTEOMICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 64. AGILENT: COMPANY SNAPSHOT

TABLE 65. AGILENT: OPERATING SEGMENTS

TABLE 66. AGILENT : PRODUCT PORTFOLIO

TABLE 67. DANAHER: COMPANY SNAPSHOT

TABLE 68. DANAHER: OPERATING SEGMENTS

TABLE 69. DANAHER: PRODUCT PORTFOLIO

TABLE 70. LI-COR, INC.: COMPANY SNAPSHOT

TABLE 71. LI-COR, INC.: OPERATING SEGMENTS

TABLE 72. LI-COR, INC.: PRODUCT PORTFOLIO

TABLE 73. PERKINELMER: COMPANY SNAPSHOT

TABLE 74. PERKINELMER: OPERATING SEGMENTS

TABLE 75. PERKINELMER: PRODUCT PORTFOLIO

TABLE 76. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

TABLE 77. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS

TABLE 78. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO

TABLE 79. HORIBA: COMPANY SNAPSHOT

TABLE 80. HORIBA: BUSINESS SEGMENTS

TABLE 81. HORIBA: PRODUCT PORTFOLIO

TABLE 82. BIO-RAD: COMPANY SNAPSHOT

TABLE 83. BIO-RAD: OPERATING SEGMENTS

TABLE 84. BIO-RAD: PRODUCT TYPE PORTFOLIO

TABLE 85. BRUKER: COMPANY SNAPSHOT

TABLE 86. BRUKER: OPERATING SEGMENTS

TABLE 87. BRUKER: PRODUCT TYPE PORTFOLIO

TABLE 88. GE HEALTHCARE: COMPANY SNAPSHOT

TABLE 89. GE HEALTHCARE: OPERATING SEGMENTS

TABLE 90. GE HEALTHCARE: PRODUCT PORTFOLIO

TABLE 91. WATERS: COMPANY SNAPSHOT

TABLE 92. WATERS: OPERATING SEGMENTS

TABLE 93. WATERS: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. GLOBAL PROTEOMICS MARKET SEGMENTATION

FIGURE 02. TOP WINNING STRATEGIES, 2016–2019

FIGURE 03. TOP WINNING STRATEGIES, PERCENTAGE & DISTRIBUTION, 2016–2019

FIGURE 04. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES

FIGURE 05. TOP INVESTMENT POCKETS

FIGURE 06. TOP PLAYER POSITIONING, 2017

FIGURE 07. HIGH BARGAINING POWER OF BUYERS

FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS

FIGURE 09. MODERATE THREAT OF NEW ENTRANTS

FIGURE 10. MODERATE THREAT OF SUBSTITUTION

FIGURE 11. MODERATE COMPETITIVE RIVALRY

FIGURE 12. DRIVERS, RESTRAINTS, AND OPPORTUNITIES

FIGURE 13. PROTEOMICS REAGENTS MARKET FOR MICROARRAY, 2017–2025 ($MILLION)

FIGURE 14. PROTEOMICS REAGENTS MARKET FOR SPECTROMETRY, 2017–2025 ($MILLION)

FIGURE 15. PROTEOMICS REAGENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2017–2025 ($MILLION)

FIGURE 16. PROTEOMICS REAGENTS MARKET FOR CHROMATOGRAPHY, 2017–2025 ($MILLION)

FIGURE 17. PROTEOMICS REAGENTS MARKET FOR ELECTROPHORESIS, 2017–2025 ($MILLION)

FIGURE 18. PROTEOMICS REAGENTS MARKET FOR IMMUNOASSAY, 2017–2025 ($MILLION)

FIGURE 19. PROTEOMICS REAGENTS MARKET FOR PROTEIN FRACTIONATION REAGENTS, 2017–2025 ($MILLION)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS REAGENTS MARKET, BY COUNTRY, 2017 & 2025 (%)

FIGURE 21. PROTEOMICS INSTRUMENTS MARKET FOR MICROARRAY, 2017–2025 ($MILLION)

FIGURE 22. PROTEOMICS INSTRUMENTS MARKET FOR SPECTROMETRY, 2017–2025 ($MILLION)

FIGURE 23. PROTEOMICS INSTRUMENTS MARKET FOR MASS SPECTROMETRY, 2017–2025 ($MILLION)

FIGURE 24. NMR SPECTROMETRY PROTEOMICS INSTRUMENTS MARKET, 2017–2025 ($MILLION)

FIGURE 25. PROTEOMICS INSTRUMENTS MARKET FOR CHROMATOGRAPHY, 2017–2025 ($MILLION)

FIGURE 26. PROTEOMICS INSTRUMENTS MARKET FOR HPLC SYSTEMS, 2017–2025 ($MILLION)

FIGURE 27. PROTEOMICS INSTRUMENTS MARKET FOR ION CHROMATOGRAPHY, 2017–2025 ($MILLION)

FIGURE 28. PROTEOMICS INSTRUMENTS MARKET FOR AFFINITY CHROMATOGRAPHY, 2017–2025 ($MILLION)

FIGURE 29. PROTEOMICS INSTRUMENTS MARKET FOR SUPERFICIAL FLUID CHROMATOGRAPHY, 2017–2025 ($MILLION)

FIGURE 30. PROTEOMICS INSTRUMENTS MARKET FOR ELECTROPHORESIS, 2017–2025 ($MILLION)

FIGURE 31. PROTEOMICS INSTRUMENTS MARKET FOR SURFACE PLASMON RESONANCE, 2017–2025 ($MILLION)

FIGURE 32. PROTEOMICS INSTRUMENTS MARKET FOR X-RAY CRYSTALLOGRAPHY, 2017–2025 ($MILLION)

FIGURE 33. PROTEOMICS INSTRUMENTS MARKET FOR PROTEIN FRACTIONATION SYSTEMS, 2017–2025 ($MILLION)

FIGURE 34. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2017 & 2025 (%)

FIGURE 35. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS SERVICES MARKET, BY COUNTRY, 2017 & 2025 (%)

FIGURE 36. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2017 & 2025 (%)

FIGURE 37. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 38. COMPARATIVE SHARE ANALYSIS OF PROTEOMICS MARKET FOR OTHER, BY COUNTRY, 2017 & 2025 (%)

FIGURE 39. AGILENT: REVENUE, 2015–2017 ($MILLION)

FIGURE 40. AGILENT: REVENUE SHARE BY OPERATING SEGMENT, 2017 (%)

FIGURE 41. AGILENT: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 42. DANAHER: NET SALES, 2015–2017 ($MILLION)

FIGURE 43. DANAHER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 44. DANAHER: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 45. PERKINELMER: NET SALES, 2015–2017 ($MILLION)

FIGURE 46. PERKINELMER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 47. PERKINELMER: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 48. THERMO FISHER SCIENTIFIC: REVENUE, 2015–2017 ($MILLION)

FIGURE 49. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2017 (%)

FIGURE 50. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY REGION, 2017 (%)

FIGURE 51. HORIBA: NET SALES, 2015–2017 ($MILLION)

FIGURE 52. HORIBA: NET SALES, BY SEGMENT, 2017 (%)

FIGURE 53. HORIBA: NET SALES, BY REGION, 2017 (%)

FIGURE 54. BIO-RAD: NET SALES, 2015–2017 ($MILLION)

FIGURE 55. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 56. BIO-RAD: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 57. BRUKER: NET SALES, 2015–2017 ($MILLION)

FIGURE 58. BRUKER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 59. BRUKER: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 60. GE HEALTHCARE: NET SALES, 2015–2017 ($MILLION)

FIGURE 61. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 62. GE HEALTHCARE: REVENUE SHARE BY REGION, 2017(%)

FIGURE 63. WATERS: NET SALES, 2015–2017 ($MILLION)

FIGURE 64. WATERS: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 65. WATERS: REVENUE SHARE BY REGION, 2017 (%